Supplemented Food or NHP? How Canada's Natural Health Products Regulations Draw the Line

Here’s a situation we see more often than it should happen: a Canadian nutraceutical company launches a protein powder fortified with B-vitamins, magnesium, and ashwagandha extract. They design the label with a Supplemented Food Facts table, skip the NPN application, and get the product into retail. Eighteen months later, Health Canada flags the ashwagandha — a botanical with documented adaptogenic properties that isn’t on the permitted supplemented food ingredient lists — and the company is staring down a voluntary recall and a mandatory product reformulation. The cost isn’t just regulatory. It’s inventory, retailer relationships, and six-figure sunk costs in packaging.

This scenario is preventable. But preventing it requires understanding how Canada’s two principal health product regulatory streams actually work — and exactly where they diverge.

What Canada’s Natural Health Products Regulations Actually Govern (and What They Don’t)

Canada’s Natural Health Products Regulations (SOR/2003-196), enacted under the Food and Drugs Act, govern any product that contains a medicinal ingredient intended to diagnose, treat, mitigate, or prevent a disease, disorder, or abnormal physical state. Products subject to the NHPR require a product licence — an NPN or a DIN-HM for homeopathic medicines — before they can legally be sold in Canada. There are no exceptions based on product format or distribution channel.

The Supplemented Food Regulations (SOR/2019-130), in force since January 1, 2022, created a distinct regulatory category under Division 24 of the Food and Drug Regulations. Supplemented foods are food products — presented in a food format, carrying food-appropriate claims — that contain added vitamins, minerals, amino acids, or other specifically permitted substances from Health Canada’s approved ingredient lists. They require no pre-market product licence. Health Canada oversees them post-market, primarily through inspections and market surveillance.

The two categories don’t overlap. A product is one or the other. The challenge is that the line between them isn’t always obvious at the formulation stage — and the consequences of landing on the wrong side of it are significant.

The Five Factors That Determine Which Regulatory Pathway Applies

Health Canada doesn’t publish a single definitive decision tree for supplemented food versus NHP classification, though the agency has produced guidance documents through the Office of Natural and Non-prescription Health Products (ONNHPD) that address common scenarios. In practice, classification comes down to five factors assessed together.

Ingredient eligibility. Health Canada maintains lists of permitted supplemented food ingredients — vitamins and minerals, amino acids, and a defined set of additional permitted substances that includes caffeine (to a maximum of 400 mg per day from supplemented food ingredients), creatine, and taurine. If a product contains any ingredient outside these lists, it cannot be classified as a supplemented food — full stop. Botanical and herbal extracts such as ashwagandha, elderberry, turmeric curcumin, lion’s mane, and bacopa are not on any supplemented food permitted list. A product containing them as active ingredients must be assessed under the NHPR.

Health claims on the label and in marketing. Supplemented foods can carry nutrition-content claims and certain approved health claims permitted under the food regulations. They cannot carry therapeutic claims that connect specific ingredients to treating, preventing, or curing conditions. If your label says “supports immune function” as a general wellness statement, that may be acceptable for a supplemented food. If it says “clinically studied to reduce the duration of upper respiratory infections,” Health Canada is going to read that as a claim requiring NHP substantiation. Health Canada reviews your website and social media content, not just the label — and all channels are in scope during an inspection.

Product format and consumer expectation. Products in capsule, tablet, softgel, or similar dosage forms create an immediate presumption of medicinal use. The format signals “medicine” before a single claim is read. Powders, beverages, bars, and food-format gummies are more likely to qualify as supplemented foods — though format alone is never decisive. A gummy containing melatonin is still an NHP, regardless of how food-adjacent it appears on shelf.

Recommended daily amounts and dosing language. Therapeutic dosing language signals medicinal intent. “Take 2 capsules at the onset of symptoms” doesn’t belong on a supplemented food. Neither do recommended amounts that track against clinical dosing regimens for specific health conditions rather than the Daily Values established under the food regulations.

Integrated product positioning. Classification is assessed holistically. A brand that sells a powder labelled as a supplemented food but positions it across all marketing channels as a hormonal support product for post-menopausal women is presenting a product with NHP intent. Health Canada inspectors are trained to look at the whole picture — label, website, retailer listings, social media, influencer content. Each piece contributes to the regulatory read.

High-Risk Product Categories Where Companies Get It Wrong

Adaptogens are the single highest-risk category for misclassification. Ashwagandha, rhodiola, schisandra, and similar botanical extracts have become mainstream in the Canadian supplement market over the past decade. They’re consumer-friendly, well-supported by emerging research, and widely distributed. They’re also not permitted in supplemented foods under any circumstances. A manufacturer adding any of these to a protein powder or greens blend needs an NPN, and needs to factor in that Class II NPN applications are targeted for review in approximately 60 days, while Class III applications requiring full clinical evidence can take up to 300 business days for Health Canada to complete its review. That’s a 14-month commitment that has to be built into the launch plan at the formulation stage.

Melatonin products are categorically NHPs. Health Canada has been unambiguous on this. So are any products containing valerian root, 5-HTP, passionflower, or other ingredients whose primary function in a formula is sleep induction. The melatonin sleep gummy market is enormous in Canada right now, and every single one of those products needs a valid NPN displayed on the label.

Caffeinated products sit in genuine grey zone territory. Caffeine is permitted as a supplemented food ingredient, subject to the 400 mg/day daily maximum and mandatory advisory labelling for any product delivering more than 75 mg per serving from supplemented food ingredients. But when caffeine is combined with non-permitted botanical stimulants — guarana, ginseng positioned as an active, green tea extract used for its catechin profile — the botanical components pull the entire product into NHP territory regardless of whether the caffeine level is within supplemented food limits.

Pre-workout and sports nutrition products have historically been a compliance headache for precisely this reason. A single non-eligible ingredient removes the entire product from the supplemented food pathway.

What the Wrong Classification Decision Actually Costs

The financial exposure from misclassification is asymmetric. The cost of getting it right early — a properly scoped classification analysis, a pre-submission meeting with Health Canada where needed, and an NPN application filed on the right timeline — is bounded and manageable. The cost of getting it wrong surfaces unpredictably, often at the worst possible moment.

Under the Food and Drugs Act, selling a natural health product without a valid product licence is an offence. Summary conviction can result in fines of up to $50,000 and two years of imprisonment. For serious violations involving health risk, penalties under indictable offence provisions can reach $5 million for corporate entities. These aren’t theoretical numbers. Health Canada has escalated enforcement activity in the NHP space, and the agency publishes compliance actions publicly.

The operational costs typically exceed the fines themselves. A Stop Sale order or mandatory recall affects your entire inventory across all distribution channels simultaneously. For brands with national retail distribution, a published Health Canada recall notice is visible to every buyer and category manager who carries your SKU. Rebuilding those commercial relationships takes considerably longer than the recall process.

There’s also a manufacturing compliance dimension that often catches companies off guard. NHPs must be manufactured under NHP-specific GMP requirements, including lot release testing, documented quality control procedures, and retention samples maintained for at least one year post-expiry. Supplemented foods are manufactured under food GMP standards governed by the Safe Food for Canadians Regulations. A contract manufacturer holding a Drug Establishment Licence for NHP manufacturing is not automatically qualified to produce supplemented foods under the food regulations — and vice versa. If your classification decision changes after production has begun, your manufacturing arrangement may need to be entirely reconsidered.

Building Classification Into Product Development — Not Retroactively

The practical lesson here is that classification analysis belongs at the formulation stage. Before a formula is finalized, every active and functional ingredient should be verified against Health Canada’s permitted supplemented food ingredient lists. If any ingredient falls outside those lists, the product is an NHP. The regulatory timeline — NPN application preparation, Health Canada review, product licence issuance — needs to be factored into the launch plan from day one.

For genuinely ambiguous products, Health Canada’s ONNHPD offers pre-submission meetings where you can present your classification rationale and receive documented feedback before committing to a regulatory pathway. These aren’t fast to schedule, but they produce an interaction record that supports your compliance position if a question arises later.

Classification also needs to be embedded in your change control process. Adding a botanical ingredient to an existing supplemented food formula, changing a claim in a way that implies therapeutic action, or shifting your marketing positioning can all trigger a reclassification obligation. Products don’t stay in one regulatory category automatically — they stay there because someone is actively monitoring the factors that keep them there.

Make that someone a formal part of your quality system. It’s the kind of operational discipline Health Canada inspectors look for as evidence of a mature regulatory function — and the kind that prevents a routine market surveillance check from becoming a Stop Sale.

---

Written by Nour Abochama, Quality & Regulatory Advisor, Androxa. Learn more about our team

Talk to our team about Health Canada compliance. Contact us

Related from our network

• Supplement Ingredient Testing and Certificate of Analysis Verification — ISO 17025-accredited testing for NHP ingredient identity, potency, and contaminant screening in the US market
• EU Health Claims vs. Canadian NHP Therapeutic Claims: What Cross-Border Brands Must Know — How the EU’s health claims regulation under EC 1924/2006 compares to Canada’s NHP claim substantiation requirements